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Abstract
Despite a general role for the HIF hydroxylase system in cellular oxygen sensing and 
tumour hypoxia, cancer-associated mutations of genes in this pathway, including 
PHD2, PHD1, EPAS1 (encoding HIF-2α) are highly tissue-restricted, being observed in 
pseudohypoxic pheochromocytoma and paraganglioma (PPGL) but rarely, if ever, 
in other tumours. In an effort to understand that paradox and gain insights into the 
pathogenesis of pseudohypoxic PPGL, we constructed mice in which the principal HIF 
prolyl hydroxylase, Phd2, is inactivated in the adrenal medulla using TH-restricted Cre 
recombinase. Investigation of these animals revealed a gene expression pattern closely 
mimicking that of pseudohypoxic PPGL. Spatially resolved analyses demonstrated 
a binary distribution of two contrasting patterns of gene expression among adrenal 
medullary cells. Phd2 inactivation resulted in a marked shift in this distribution towards a 
Pnmt−/Hif-2α+/Rgs5+ population. This was associated with morphological abnormalities of 
adrenal development, including ectopic TH+ cells within the adrenal cortex and external 
to the adrenal gland. These changes were ablated by combined inactivation of Phd2 with 
Hif-2α, but not Hif-1α. However, they could not be reproduced by inactivation of Phd2 in 
adult life, suggesting that they arise from dysregulation of this pathway during adrenal 
development. Together with the clinical observation that pseudohypoxic PPGL manifests 
remarkably high heritability, our findings suggest that this type of tumour likely arises 
from dysregulation of a tissue-restricted action of the PHD2/HIF-2α pathway affecting 
adrenal development in early life and provides a model for the study of the  
relevant processes. Endocrine-Related Cancer  
(2021) 28, 757–772
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Introduction
Pheochromocytoma and paraganglioma (PPGL) are 
tumours of the autonomic paraganglia that arise in diverse 
anatomical locations from the skull base to the pelvis. 
Those found within the adrenal glands (AGs) are known 
as pheochromocytoma (PCC) and those in extra-adrenal 
structures including the carotid body are commonly 
termed paraganglioma (PGL). Molecular analysis of these 
tumours has revealed a number of subtypes or clusters, 
with distinct patterns of gene expression within the 
tumour being associated with different groups of tumour-
associated mutations. Genetic profiling has revealed four 
such subtypes: kinase signalling, Wnt-altered, cortical 
admixture and pseudohypoxia (Crona et al. 2017, Fishbein & 
Wilkerson 2018). The pseudohypoxia subtype (or Cluster I) 
is associated with mutations affecting transcriptional 
pathways induced by hypoxia.
The transcriptional response to hypoxia is mediated 
by hypoxia-inducible factor (HIF) (reviewed in Bishop & 
Ratcliffe 2014), a heterodimer consisting of an oxygen-
regulated α and a constitutively expressed β subunit. HIF-α  
is regulated by a series of 2-oxoglutarate-dependent 
dioxygenases that generate an oxygen-dependent signal by 
hydroxylation of specific prolyl residues in HIF-α subunits 
which are targeted for proteasomal degradation via the 
E3 ubiquitin ligase von Hippel-Lindau (VHL) protein. 
Mammalian species have multiple HIF-α isoforms, of 
which HIF-1α and HIF-2α are the most abundant and best 
studied. They also express three closely related isoforms 
of the HIF prolyl hydroxylase enzymes (PHD1, PHD2 and 
PHD3, otherwise known as EGLN2, EGLN1 and EGLN3), 
of which PHD2 is the most abundant and important 
regulator of HIF.
HIF is commonly activated in cancer and its role in 
oncogenesis has attracted widespread interest, particularly 
in view of the recent development of drugs with the 
potential to activate or inactivate components of the 
pathway therapeutically (reviewed in Semenza 2019, 
Choueiri & Kaelin 2020). Nevertheless, this relationship 
of HIF activation to oncogenesis has proved more complex 
than anticipated. For instance, although HIF is commonly 
upregulated in cancer, direct genetic activation by 
mutation of any of the key components of the pathway is 
rare in most forms of cancer.
The pseudohypoxic subtype of PPGLs is an important 
exception. These tumours manifest a ‘pseudohypoxic’ 
pattern of gene expression encompassing upregulation 
of certain HIF target genes, together with alterations in 
the expression of differentiation markers (Dahia  et  al. 
2005, Favier  et  al. 2009, 2012, Waldmann  et  al. 2010, 
Burnichon  et  al. 2011, Lorenzo  et  al. 2013, Toledo  et  al. 
2013, Welander et al. 2014, Yang et al. 2015, Fishbein et al. 
2017). They are associated with loss-of-function mutations 
in VHL, PHD2 and PHD1 and gain-of-function mutations 
in HIF-2α (otherwise known as EPAS1) as well as mutations 
in genes encoding the tricarboxylic acid cycle enzymes 
succinate dehydrogenase (SDHB/D/C/A or SDHx) and 
fumarate hydratase (FH) (Dahia  et al. 2005, Ladroue  et al. 
2008, Zhuang et al. 2012, Yang et al. 2015). Impaired function 
of the latter two enzymes leads to the accumulation of 
succinate and fumarate, respectively, which are able to 
inhibit 2-oxoglutarate-dependent dioxygenases including 
the HIF prolyl hydroxylases. All these mutations therefore 
have the potential to activate HIF, suggesting that in this 
setting it is HIF that provides the oncogenic drive.
However, there are a number of puzzling features in 
these associations. First, PPGLs in general manifest an 
unusually high ratio of inherited to sporadic forms. For 
instance, up to 40% of PPGLs are associated with germline 
or post-zygotic but very early somatic mutation, as assessed 
by family history or distribution of mutant cells (Buffet et al. 
2020). Secondly, the spectrum of gene dysregulation in 
pseudohypoxic PPGLs does not align exactly with that 
of dynamically regulated HIF transcriptional targets 
(Dahia et al. 2005, Favier et al. 2009, 2012, Waldmann et al. 
2010, Burnichon et al. 2011, Lorenzo et al. 2013, Toledo et al. 
2013, Welander et al. 2014, Yang et al. 2015, Fishbein et al. 
2017). Thirdly, human VHL mutations associated with 
PCCs have a complex relationship to dysregulation of HIF: 
type 1 VHL mutations, which show complete dysregulation 
of HIF, are not associated with pheochromocytoma 
whereas type 2A, B and C VHL mutations, which are 
associated with pheochromocytoma, show either less 
severe or no dysregulation of HIF, at least when assayed in 
vitro or in heterologous cell types (Kaelin 2008). Fourthly, 
Vhl inactivation in the adrenal medulla (AM) and carotid 
body of the mouse results in tissue atrophy rather than 
tumour formation (Macias et al. 2014).
In an attempt to shed light on these paradoxical 
findings and better understand the role of activation of 
HIF pathways in the AM, we have examined the effects 
of inactivation of the principal HIF prolyl hydroxylase 
Phd2 in the AM, using Cre recombinase restricted by 
the tyrosine hydroxylase (TH) promoter, in the mouse. 
We report that TH-restricted constitutive inactivation 
of Phd2 in the AM results in a ‘pseudohypoxic pattern’ 
of gene expression in which dynamic activation of HIF 
transcription is superimposed on a developmental shift 
in populations of AM cells manifesting specific patterns of 
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gene expression associated with the presence or absence 
of phenylethanolamine N-methyltransferase (PNMT). 
Changes in gene expression were accompanied by 
morphological abnormalities including ectopic TH+ cells 
within the adrenal cortex and in peri-adrenal structures. 
These findings, together with marked differences between 
constitutive and inducible inactivation of Phd2 in adult 
life, suggest that the pathological activation of the PHD2/
HIF-2 pathway during adrenal development is critical for 
its tumourigenic action.
Methods
Ethical approval and animals
Animal experimental protocols were approved by the 
University of Oxford Medical Science Division Ethical 
Review Committee and are compliant with the UK 
Home Office Animals (Scientific Procedures) Act 1986. 
Experiments were performed on ~3 month-old mice and 
sex-matched controls, unless stated otherwise. Mice were 
kept in individually ventilated cages with free access 
to water and food. Phd2f/f, Hif-1αf/f and Hif-2αf/f alleles 
are as described (Cramer  et  al. 2003, Gruber  et  al. 2007, 
Mazzone  et  al. 2009). Note that Phd2 is equivalent to 
Egln1 and Hif-2α is equivalent to Epas1; we have used 
the Phd2/Hif-2α terminology to simplify mechanistic 
interpretation for the reader. TH+ cell-specific inactivation 
was achieved using the constitutively expressed TH-IRES-
Cre (THCre; Lindeberg et  al. 2004) or inducible TH-IRES-
CreER (THCreER; Rotolo et  al. 2008) and ubiquitous 
inactivation using the inducible Rosa26CreERT2 (RosaCreER; 
Vooijs et al. 2001). Each mouse line was backcrossed with 
C57BL/6 for at least five generations.
Drug administration
For adult-onset Phd2 inactivation, ~6 week-old mice were 
dosed once daily with 2 mg tamoxifen orally (20 mg/mL in 
corn oil containing 10% ethanol, Sigma) for 5 consecutive 
days. Phd2f/f;RosaCreER and Phd2f/f;THCreER mice were 
sacrificed 17 days or ~3 months, respectively, after the start 
of treatment.
Tissue collection
Animals were killed by an overdose of isoflurane (Piramal 
Critical Care, West Drayton, UK) and exsanguination 
from the inferior vena cava. Blood was collected using 
heparinised needles. AGs for RT-qPCR were dissected 
into ice-cold phosphate buffered saline (PBS, in mM: 
137 NaCl, 2.7 KCl, 4 Na2H2PO4.7H2O, 1.5 KH2PO4) in 
diethyl pyrocarbonate-treated water (0.1%, v/v, Sigma). 
For histology, mice were perfused-fixed with 5 mL PBS 
followed by 5 mL 4% paraformaldehyde (PFA)/PBS (w/v) 
(Sigma). Dissected AGs were fixed in 4% PFA/PBS overnight, 
transferred into 70% (v/v) ethanol then dehydrated in an 
ascending ethanol series ending in histoclear (National 
Diagnostics, Atlanta, US), embedded in 60°C paraffin 
and sectioned to 4 μm thickness with a Microm HM 355S 
microtome (Thermo Fisher Scientific).
Catecholamine measurements
Blood was centrifuged at 800 g for 5 min and plasma 
was separated and stored at −80°C. Adrenaline and 
noradrenaline were detected in diluted plasma samples 
using the Epinephrine/Norepinephrine ELISA Kit (KA1877, 
Abnova, Taoyuan City, Taiwan). Signal absorbance was read 
at 450 nm using a FLUOstar Omega microplate reader (BMG 
Labtech, Aylesbury, UK). Catecholamine concentrations 
were calculated using a linear standard curve.
Immunohistochemistry
Sections were immunostained for TH using an EnVision+ 
kit (Dako Denmark A/S) with a polyclonal rabbit anti-TH 
antibody (1:5000, NB300-109, Novus Biologicals, 
Cambridge, UK) (Bishop et al. 2013).
In situ hybridisation
mRNA was detected in sections using the manual RNAScope 
2.5 HD BROWN assay or, for dual in situ hybridisation, the 
RNAScope 2.5 HD Duplex assay (Advanced Cell Diagnostics, 
Newark, US). RNAScope probes: Mm-Pnmt (426421 or 
426421-C2 for dual RNAScope), Mm-Epas1 (314371), 
Mm-Rgs5 (430181), Mm-Vegfa-OI (43961). Imaging was 
performed with a Leica DM 1000 LED microscope (Leica 
Biosystems).
Proximity ligation in situ hybridisation (PLISH)
Multiplex fluorescence in situ hybridisation was 
performed using PLISH (Nagendran et al. 2018). Sections 
were de-paraffinised, boiled in a 10 mM citrate buffer 
(pH 6.0) with 0.05% lithium dodecyl sulfate (Sigma) 
and processed in sealed hybridisation chambers 
(Grace Biolabs, Bend, US). Tissues were treated with 
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0.1 mg/mL Pepsin (Roche-10108057001, Sigma-Aldrich) 
in 0.1 M HCl, followed by (at 37°C): hybridisation 
of barcoded gene probes and bridge sequences, DNA 
ligation (10 CEU/mL T4 DNA ligase, M0202T, New 
England Biolabs, Ipswich, US) and extension by rolling 
circle amplification (1 U/mL Nxgen phi29 polymerase, 
Lucigen, Middleton, US). Samples were incubated with 
fluorophore-conjugated oligonucleotides specific to the 
barcode for the targeted gene probe (Supplementary 
Methods, see section on supplementary materials 
given at the end of this article), washed then treated 
with TruVIEW autofluoresence quenching kit (Vector 
Laboratories, Burlingame, US), stained with DAPI and 
mounted. Imaging was performed with a Zeiss Axio 
Imager M1 microscope (Jena, Germany) and analysed 
with Qupath software (Bankhead et al. 2017).
Morphometric analysis
AM volume was modelled by measuring the TH+ area of 
one in eight consecutive slides of the AG using ImageJ 
software (NIH) (Bishop  et  al. 2008, Fielding  et  al. 2018). 
In situ hybridisation signal was quantified using trainable 
Weka segmentation plugin in Fiji ImageJ 1.53c software 
(NIH) (Cheng et al. 2020).
RT-qPCR
AGs were collected from five mice per genotype and 
AMs sub-dissected under an SMZ-745 stereo microscope 
(Nikon) and stored in RNAProtect (Qiagen) on ice. Pooled 
tissues were homogenised in RLT+ buffer (Qiagen) using a 
ProScientific PRO200 Homogenizer (Cole-Parmer, Eaton 
Socon, UK). RNA was isolated using the RNeasy Plus Micro 
Kit (Qiagen), cDNA prepared using the QuantiTect RT 
Kit (Qiagen) and RT-qPCR performed with the TaqMan 
Fast Advanced Master Mix Kit (Thermo Fisher Scientific) 
in the StepOnePlus Real-Time PCR System (Applied 
Biosystems). Three technical replicates were used in each 
biological repeat with Actb serving as a reference gene 
(see Supplementary methods for TaqMan probes). Fold 
change in gene expression was reported as 2−ΔΔCT, where 
ΔΔCT = Phd2f/f;THCre (CTtarget – CTreference) – Phd2f/f 
(CTtarget – CTreference).
Statistical analysis
Data are shown as mean ± s.e.m. Statistical analyses 
were performed using unpaired Student’s t-tests, unless 
otherwise stated, and using GraphPad Prism 9.0 Software.
Results
Since pseudohypoxic PPGLs have a characteristic gene 
expression profile, we first sought to test whether and 
to what extent this was mimicked by Phd2 inactivation 
in the AM. To this end, we intercrossed mice bearing a 
conditionally inactivated (Phd2f/f) allele with a transgenic 
line expressing Cre recombinase restricted by the TH 
promoter (THCre) to generate Phd2f/f;THCre mice and 
measured effects on the expression of a panel of 14 genes 
that are frequently dysregulated in pseudohypoxic PPGLs 
(Supplementary Table 1). This comprised several classes of 
genes, including HIF target genes Vegfa, Slc2a1 and Ldha; 
atypical mitochondrial subunits Ndufa4l2 and Cox4i2; 
G-protein signalling pathway components Rgs4, Rgs5 and 
Adora2a; Pnmt, the terminal enzyme in catecholamine 
synthesis; genes with oncogenic potential including Stc1.
These experiments revealed that many, though not 
all, genes identified as dysregulated in pseudohypoxic 
PPGLs were also dysregulated in a similar way in the AM 
of Phd2f/f;THCre mice (Fig. 1A), suggesting that their 
expression is directly or indirectly altered as a consequence 
of dysregulation of the PHD2/HIF system in this setting. 
Interestingly, not all these genes have been identified 
as being dynamically regulated by HIF itself in the 
manner observed. In particular, Pnmt has been reported 
to be upregulated by HIF-1 in rat pheochromocytoma 
PC12 cells (Tai  et  al. 2009), whereas we observed striking 
downregulation of Pnmt (mRNA and protein) with Phd2 
inactivation/HIF activation (Fig. 1A and Supplementary 
Fig. 1). PNMT is the terminal enzyme in the catecholamine 
synthesis pathway which converts noradrenaline 
into adrenaline. In keeping with the loss of Pnmt, we 
observed a shift in plasma catecholamines: an increase 
in noradrenaline together with a reduction in adrenaline 
(Fig. 1B). This predominantly noradrenergic secretory 
profile, together with a loss of Pnmt expression, is similar to 
clinical observations in patients with pseudohypoxic PCCs 
(Eisenhofer et al. 2001).
We therefore sought to determine whether Phd2f/f; 
THCre mice have morphological features of PCC, in 
particular evidence of intra-adrenal pathology. However, 
no frank tumours, nodules, cortical compression or loss of 
nest-like/formation of sheet-like chromaffin cell clusters 
(Smith-Hicks et al. 2000, Park et al. 2015) were observed, and 
there was no change in overall AM volume or proliferation 
(Supplementary Table 2).
However, we noted striking abnormalities of adrenal 
morphology, in particular the abnormal location of TH+ 
cells. These comprised clusters of ectopic cells in the 
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adrenal cortex that disrupt the outer cortical boundary, 
adjacent to a TH+ extra-adrenal ganglion-like structure (Fig. 
1C). Altogether, 11 out of 14 Phd2f/f;THCre mice and 0 out of 
15 littermate controls manifest these abnormalities.
TH+ chromaffin cells migrate through the adrenal cortex 
to reach their final destination in the AM (Furlan et al. 2017, 
Hanemaaijer  et al. 2021), during which time they acquire 
Pnmt expression in the final stages of maturation to become 
adrenergic (Verhofstad et al. 1979). We therefore considered 
whether the abnormally located TH+ cells (both within and 
directly adjacent to the AG) represent abnormal migration 
of chromaffin cells and that the reduction in Pnmt might 
also reflect failure to acquire Pnmt due to dysregulated/
arrested development with Phd2 inactivation.
To address this, we proceeded to analyse the spatial 
distribution of gene expression within the AM. The normal 
AG is known to express Pnmt in a restricted set of mature 
chromaffin cells that produce adrenaline (Coupland & 
Hopwood 1966). Analysis of the spatial distribution of 
Pnmt expression in WT mice confirmed this, with the 
majority (~75%) of chromaffin cells expressing Pnmt (Fig. 
2A). We next considered whether this expression pattern 
extended to other genes which were dysregulated in AMs 
with loss of Phd2. The following genes were selected for 
analysis: Hif-2α, since its upregulation is characteristic of 
VHL-associated neoplasia including PCCs (Toledo 2017); 
Vegfa and Rgs5, since these are reported HIF target genes 
(Jin  et  al. 2009, Fielding  et  al. 2018) and the latter is also 
a proposed regulator of chromaffin cell differentiation 
(Chan  et  al. 2019, Hanemaaijer  et  al. 2021). These 
experiments revealed a striking inverse pattern of gene 
expression, with Hif-2α and Rgs5 mRNA being expressed 
Figure 1
Effect of TH-restricted Phd2 inactivation on gene expression, plasma catecholamines and AM morphology. (A) Gene expression profile of AMs in 
Phd2f/f;THCre mice (relative to Phd2f/f controls), analysed by RT-qPCR on RNA extracted from ten AMs per biological replicate. Data for individual genes 
were analysed by unpaired two-tailed Student’s t-tests. Gene expression pattern in Phd2f/f;THCre AMs resembles that of pseudohypoxic PPGLs. (B) Plasma 
catecholamine levels in Phd2f/f;THCre (vs Phd2f/f control) mice. Data were analysed by a two-way ANOVA, interaction (Phd2 inactivation vs noradrenaline/
adrenaline ratio) P < 0.0001 followed by Sidak’s multiple comparisons test. Graph shows a reduction in adrenaline and an increase in noradrenaline in 
the plasma of Phd2f/f;THCre mice. (C) Representative images of Phd2f/f;THCre (compared with Phd2f/f control) AGs. The AM is encircled with a black dashed 
line in this and other figures. TH antibody (brown); Harris haematoxylin counterstain (blue). Enlarged images show ectopic TH+ cells in the adrenal cortex 
(red frame) and in a peri-adrenal structure (black frame). Scale bars: 0.5 mm (far and middle left panels); 0.1 mm (red frame); 0.05 mm (black frame). 
Data show mean ± s.e.m. *P < 0.05, ****P < 0.0001.
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Figure 2
Effect of Phd2 inactivation on the spatial expression of genes in the AM. (A) In situ hybridisation for Pnmt, Hif-2α, Rgs5 and Vegfa mRNA (brown) in adjacent 
sections of a WT AG showing Hif-2α and Rgs5 mRNA expression in Pnmt− cells. Gill’s haematoxylin counterstain (grey-blue). Scale bars: 0.2 mm. (B) 
Comparison of Pnmt, Hif-2α, Rgs5 and Vegfa mRNA expression in Phd2f/f vs Phd2f/f;THCre AMs. Red dashed lines outline Pnmt−/Hif-2α+/Rgs5+ cell populations 
in this and other figures. Images show a switch from predominantly Pnmt+/Hif-2α−/Rgs5− to Pnmt−/Hif-2α+/Rgs5+ cells following Phd2 inactivation. Harris 
haematoxylin counterstain (blue). Scale bars: 0.1 mm.
https://doi.org/10.1530/ERC-21-0211
https://erc.bioscientifica.com © 2021 The authors
Printed in Great Britain
Published by Bioscientifica Ltd.
This work is licensed under a Creative Commons 
Attribution 4.0 International License.
763L Eckardt, M Prange-
Barczynska et al.
The role of PHD2 in 
pseudohypoxic PCCs
28:12Endocrine-Related 
Cancer
only in the normal AM cells that do not express Pnmt 
(Fig. 2A). Vegfa, on the other hand, could not be detected, 
except in the adrenal cortex where it was strongly expressed 
(Fig. 2A). This suggested the possibility that a binary, cell-
specific pattern of expression exists within AM cells, with 
low Pnmt associating with high Hif-2α and upregulation of 
at least some of its transcriptional targets such as Rgs5.
The findings therefore raised the interesting 
question as to whether inactivation of Phd2 might affect 
the expression of these genes (Pnmt, Hif-2α, Rgs5 and 
Vegfa) within a specific population of cells or whether 
the prevalence of the two populations manifesting the 
observed patterns of gene expression might change after 
Phd2 inactivation. To address this, we performed further 
in situ mRNA hybridisation studies. These studies revealed 
a major switch of cell populations in AMs following Phd2 
inactivation. The same pattern of Pnmt−/Hif-2α+/Rgs5+ 
was maintained, but cells manifesting this pattern now 
became the dominating cell population distributed across 
most of the AM with the exception of small areas around 
the periphery (Fig. 2B). Within the dominating population 
of Pnmt−/Hif-2α+/Rgs5+ expressing cells, there was also 
a mild induction of the HIF target gene Vegfa (Fig. 2B). 
This inverse expression of Pnmt and Hif-2α/Rgs5/Vegfa in 
Phd2f/f and Phd2f/f;THCre AMs was confirmed by dual in 
situ hybridisation and PLISH, which allow multiplexing of 
different mRNA probes to measure overlapping patterns of 
expression (Fig. 3 and Supplementary Fig. 2).
We next went on to examine the ectopic TH+ cells 
within the adrenal cortex. Interestingly, essentially 
Figure 3
Spatial co-localisation of genes in the AM. (A) Dual in situ hybridisation or (B) proximity ligation in situ hybridisation (PLISH) for Pnmt, Hif-2α, Rgs5 and Vegfa 
mRNA in Phd2f/f and Phd2f/f;THCre AMs. Pnmt expression in cells inversely correlates with Hif-2α and Rgs5 in both genotypes but Pnmt+/Hif-2α−/Rgs5− cell 
populations are dominant in Phd2f/f whereas this switches to Pnmt−/Hif-2α+/Rgs5+ cells in Phd2f/f;THCre AMs, which additionally show induction of Vegfa. 
For dual in situ hybridisation, Gill’s haematoxylin counterstain (grey-blue). Scale bars for dual in situ hybridisation: 0.1 mm, for PLISH: 0.05 mm.
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all these cells were Pnmt−/Hif-2α+/Rgs5+/Vegfa+ (Fig. 4) 
(and negative for the adrenal cortical cell marker 
Cyp11a1, Supplementary Fig. 3), again suggestive of 
arrested migration of an immature Pnmt− population 
of chromaffin cells within the adrenal cortex during 
development. Taken together, these experiments suggest 
that TH-restricted Phd2 inactivation results in a pattern of 
gene expression similar to that of pseudohypoxic PPGLs. 
Morphological abnormalities suggestive of an effect on 
adrenal development were coupled to a major switch in an 
apparently binary pattern of gene expression observed in 
populations of cells within the AM.
To further understand this process, we intercrossed 
animals to generate Phd2f/f;Hif-1αf/f;THCre and Phd2f/f; 
Hif-2αf/f;THCre mice, which were examined with 
respect to the above phenotypes. No reversion of the 
morphological phenotype was observed with concomitant 
Hif-1α inactivation (Fig. 5). In striking contrast, Hif-2α 
inactivation (Phd2f/f;Hif-2αf/f;THCre mice) completely 
reversed all the morphological abnormalities associated 
with Phd2 inactivation, such that AMs were similar to 
those of control (Phd2f/f) mice (Fig. 5). Similar results 
were obtained with analysis of Pnmt, Rgs5 and Vegfa gene 
expression. The inverse expression pattern of Pnmt and 
Rgs5 was invariant, but the proportion of cells of each 
type was strikingly different, with Phd2f/f;Hif-1αf/f;THCre 
mice retaining a dominant population of Pnmt−/Rgs5+ cells 
while Phd2f/f;Hif-2αf/f;THCre mice apparently reverted to 
a phenotype indistinguishable from controls, including 
loss of Vegfa mRNA (Fig. 5). Together, this indicates that 
Hif-2α, not Hif-1α, is necessary for the abnormal phenotype 
resembling pseudohypoxic PCCs.
We therefore hypothesised that inactivation of 
Phd2 might have at least two distinct effects in order to 
generate this pseudohypoxic phenotype: first, a dynamic 
induction of HIF transcriptional target genes including 
Vegfa; secondly, a switch to an immature noradrenergic 
cellular phenotype within the AM. Since we also observed 
morphological abnormalities suggestive of interrupted 
differentiation and/or migration, we sought to determine 
whether these components of the pseudohypoxic 
phenotype might reflect an action of the PHD2/HIF-2 
axis during differentiation. To test this, we proceeded 
to compare the effects with those in animals where 
inactivation of Phd2 was restricted to adult life, using two 
different models. We analysed adult Phd2f/f;THCreER at 3 
months after inducing recombination with tamoxifen. 
To assess any effect of more extensive recombination, 
adult Phd2f/f;RosaCreER mice were also studied. Since these 
develop systemic abnormalities (Hodson et al. 2016), they 
were studied somewhat earlier, approximately 17 days after 
tamoxifen dosing.
In striking contrast to Phd2f/f;THCre mice, inactivation 
of Phd2 in adult mice by either protocol did not result in 
morphological abnormalities or a change in the spatial 
distribution of Pnmt− and Pnmt+ cells (Fig. 6). Additionally, 
no change in AM volume or proliferation was noted 
(Supplementary Table 2). In contrast, induction of Rgs5 
and Vegfa mRNA was observed in both models of adult-
onset Phd2 inactivation and was apparently confined to 
the population of cells that did not express Pnmt and were 
Hif-2α+ (Figs 6, 7 and Supplementary Fig. 4). Together, 
this suggests that two distinct effects of HIF-2 activation 
contribute to the pseudohypoxic phenotype observed 
with TH-restricted Phd2 inactivation: first, as a regulator 
of chromaffin cell differentiation during development; 
secondly, as a dynamic regulator of HIF target gene 
expression within Hif-2α expressing cells.
Discussion
Our findings demonstrate that TH-restricted inactivation 
of Phd2 results in a pattern of gene expression within the 
AM that resembles pseudohypoxic PPGLs. Importantly, 
several lines of evidence reveal that in addition to 
dynamic activation of the HIF transcriptional response, 
this alteration in gene expression reflects developmental 
consequences of Phd2 inactivation on the AM. First, 
the alteration in gene expression involves spatial 
changes in cell-specific patterns of gene expression that 
reflect lack of terminal differentiation to Pnmt+ cells. 
Secondly, several of the genes involved in the altered 
pattern of expression, including Pnmt and Hif-2α itself, 
are not dynamic HIF transcriptional targets. Thirdly, 
altered patterns of gene expression were associated with 
morphological abnormalities, including ectopic TH+ cell 
populations with a Pnmt− pattern of gene expression. 
Finally, neither the spatial change in gene expression 
within the AM nor the morphological abnormalities 
in the position of TH+ cells could be induced by Phd2 
inactivation in adult life.
These findings are of particular interest when 
considered alongside several unusual observations 
on the clinical genetics of PPGL. Mutations that 
directly affect components of the PHD-HIF system are 
frequently observed in the uncommon syndrome of 
pseudohypoxic PPGL, but rarely, if ever, seen in other 
much more common forms of cancer. This is surprising 
since dynamic regulation of the transcriptional response 
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Figure 4
Gene expression profile of the ectopic TH+ cell tracks in adrenal glands from Phd2f/f;THCre mice. Representative images of ectopic TH+ cells in the adrenal 
cortex from two different adrenal glands (left vs middle and right hand columns) from Phd2f/f;THCre mice showing TH protein and Pnmt, Hif-2α, Rgs5 and 
Vegfa mRNA. TH+ cells in these ectopic tracks are essentially all Pnmt−/Hif-2α+/Rgs5+/Vegfa+. Harris haematoxylin counterstain (blue). Scale bars: 0.05 mm 
(left column), 0.5 mm (middle column), 0.2 mm (right column).
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to hypoxia by the PHD-HIF system is a general function 
observed in all cells. In addition, pseudohypoxic PPGL is 
associated with a very much higher incidence of germline 
(or post-zygotic but early somatic) mutations vs sporadic 
mutations, as compared to other forms of neoplasia.
Our findings suggest a mechanism by which these 
apparently paradoxical findings could be explained. 
Specifically, the observation that dysregulation of the PHD-
HIF system has a tissue-specific action on AM development 
suggests that these tumours have origins in early life, with 
Figure 5
Effect of combined Hif-α and Phd2 inactivation on morphological abnormalities and gene expression in the AM. Representative images of TH 
immunohistochemistry and in situ hybridisation for Pnmt, Rgs5 and Vegfa mRNA in Phd2f/f, Phd2f/f;THCre, Phd2f/f;Hif-1αf/f;THCre and Phd2f/f;Hif-2αf/f;THCre 
AMs. Concomitant inactivation of Hif-2α and Phd2 (but not Hif-1α and Phd2) reverses the morphological and gene expression changes observed in 
Phd2f/f;THCre mice such that these AMs resemble those of control (Phd2f/f) mice. Harris haematoxylin counterstain (blue). Scale bars: 0.5 mm (top row),  
0.1 mm (lower panels).
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Figure 6
Effect of adult-onset Phd2 inactivation on morphology and gene expression in the AM. (A) Representative images of TH protein and Pnmt and Rgs5 mRNA 
in adrenal glands from Phd2f/f;THCreER, Phd2f/f;RosaCreER (and their respective Phd2f/f controls) killed ~3 months or 17 days post tamoxifen treatment, 
respectively. Harris haematoxylin counterstain (blue). Scale bars: 0.5 mm (top row) or 0.2 mm (bottom two rows). (B) Quantification of the percentage of 
Pnmt+ and Rgs5+ AM area; AMs from Phd2f/f;THCre, Phd2f/f;THCreER and Phd2f/f;RosaCreER mice (filled bars and rhombi) and their respective controls (open 
bars and rhombi). Bars show mean ± s.e.m. Data within individual genotype groups were compared by unpaired two-tailed Student’s t-tests: *P < 0.05,  
**P < 0.01, ****P < 0.0001. Adult-onset Phd2 inactivation did not phenocopy morphological abnormalities or Pnmt loss in the AM observed with 
early-onset Phd2 inactivation, although a small but significant induction in Rgs5+ was noted within the Pnmt− cells of Phd2f/f;THCreER AMs.
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PHD2-dependent cell differentiation changes predisposing 
to subsequent tumourigenesis. Interestingly, inactivation 
of the related HIF prolyl hydroxylase isoform PHD3 prevents 
developmental culling of neurons, and this has also 
been proposed to pre-dispose to tumours (Lee et al. 2005, 
Bishop  et  al. 2008). Consistent with the relevance of our 
findings to the human syndrome, we found that changes 
in adrenal morphology and gene expression were ablated 
by inactivation of Hif-2α, but not Hif-1α, in line with the 
observation that activating mutations in HIF-2α, but not 
Figure 7
Spatial distribution of gene expression in the AM with constitutive or adult-onset Phd2 inactivation. Representative images of in situ hybridisation for 
Pnmt, Hif-2α, Rgs5 and Vegfa mRNA in Phd2f/f;THCre (constitutive) or Phd2f/f;THCreER (adult-onset) mice and their respective controls. Pnmt expression in 
cells inversely correlates with Hif-2α and Rgs5 across all genotypes but the Pnmt+/Hif-2α−/Rgs5− cell population is dominant in Phd2f/f controls whereas this 
switches to Pnmt−/Hif-2α+/Rgs5+ cells in Phd2f/f;THCre AMs. This contrasts to Phd2f/f;THCreER AMs, where Pnmt+/Hif-2α−/Rgs5− cells remain the dominant 
population; additionally, Rgs5 and Vegfa are induced within the minority population of Pnmt−/Hif-2α+/Rgs5+ cells compared to control mice. Harris 
haematoxylin counterstain (blue). Scale bars: 0.05 mm.
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HIF-1α, are associated with human PPGL (Buffet et al. 2020). 
The finding of extra-adrenal tissue reported in our study 
might also be relevant to the not infrequent occurrence 
of chromaffin cell tumours at extra-adrenal sites (Tischler 
2008). Although a correlation between the distribution of 
chromaffin tissue and paraganglioma has been reported 
(Coupland 1965), our data raises the possibility that these 
extra-adrenal PGLs may arise due to impaired migration 
and differentiation of sympathetic precursors that would 
normally populate the adrenal primordia to acquire 
features of mature, adrenergic chromaffin cells during 
development (Furlan et al. 2017, Hanemaaijer et al. 2021).
The precise action of HIF-2 in promoting abnormal 
adrenal development will require further investigation, 
including the dissection of effects on differentiation, 
migration and interaction with other processes including 
innervation (Vollmer 1996). Notably, inactivation of Hif-2α 
in the setting of Phd2 inactivation (Supplementary Fig. 5) 
did not obliterate Pnmt−/Rgs5+ cells in Phd2f/f;Hif-2αf/f; 
THCre mice. Furthermore, in the normal AM, Pnmt− cells 
that show increased Hif-2α and Rgs5 mRNA levels did 
not express detectable levels of HIF-2α protein (data not 
shown). Thus, in this cell population, HIF-2 does not 
appear necessary to generate a Pnmt−/Hif-2α+/Rgs5+ or 
noradrenergic phenotype; nor is HIF-2 necessary for PNMT 
acquisition in adrenergic cells, as evidenced from the 
normal AMs in Hif-2αf/f;THCre mice (Macias et al. 2018) as 
well as in Phd2f/f;Hif-2αf/f;THCre mice reported here. Rather, 
excess stabilisation of HIF-2α acts in some way to interrupt 
a developmental programme that ordinarily generates 
Pnmt+ in other AM cells.
Although Phd2 inactivation resulted in changes 
characteristic of pseudohypoxic PCCs, in this model we 
did not detect frank PCCs in ~3 month-old mice. Since PCC 
development might have a longer latency, we also analysed 
older cohorts of animals but again did not observe PCC 
development in n  = 7 Phd2f/f;THCre and littermate control 
mice analysed aged ~18 months. However, we did observe 
three TH+, chromogranin A+ nodules of chromaffin cells 
amongst a group of n  = 11 Phd2f/f;Hif-1αf/f;THCre mice aged 
in parallel (Supplementary Fig. 6). The significance of this 
is unclear, but HIF-1α has been reported to act as a tumour 
suppressor in VHL-associated renal clear cell carcinoma 
(Shen  et  al. 2011), and it may be that HIF-1 also has a 
tumour suppressive role in this context.
Our findings have relevance for both experimental 
and clinical research into PCC. They suggest that it may 
also be useful to revisit mouse models of pseudohypoxic 
PCC including models of inactivation of Sdhx that have 
not resulted in PCC (Piruat et al. 2004, Bayley et al. 2009, 
Díaz-Castro  et  al. 2012, Macias  et  al. 2014, Lepoutre-
Lussey  et  al. 2016, Al Khazal  et  al. 2021), to assess 
whether a switch from Pnmt+/Hif-2α−/Rgs5− to Pnmt−/ 
Hif-2α+/Rgs5+ cell populations also occurs in these 
settings. At the clinical level, our findings suggest that 
attempts at prevention or treatment should rationally 
include a focus on early life. Interestingly, patients with 
congenital cyanotic heart disease (a condition associated 
with life-long hypoxaemia beginning perinatally) have 
been reported to be susceptible to PCCs, many of which 
harbour sporadic HIF-2α mutations (Opotowsky  et  al. 
2015, Vaidya  et  al. 2018); our data suggests that it is the 
early-onset hypoxia in these patients which predisposes 
to subsequent PCC formation.
Interestingly, the HIF-2-dependent effects of Phd2 
inactivation, including paraganglioma-like carotid 
bodies (Fielding  et  al. 2018), are strikingly different from 
those of Vhl inactivation in catecholaminergic tissues 
using the same THCre promoter as in this study, which 
results in atrophy of multiple organs of the sympathetic 
nervous system, including the AM and the carotid body 
(Macias et al. 2014). There is a complex association between 
mutations in VHL disease and the tumour phenotypes, 
with type 2 VHL mutations that result in PCCs having 
only modest (or minimal) effects on HIF dysregulation, 
while type 1 mutations do not develop PCCs and result 
in greater HIF stabilisation (Kaelin 2008). Although levels 
of HIF activation have not been compared directly, our 
findings support the hypothesis that more moderate HIF 
activation associated with inactivation of a single PHD 
(as opposed to another function of VHL distinct from 
an action on HIF) is the most likely explanation for this 
paradox.
Several other aspects of the dysregulated gene 
expression pattern merit comment. In particular, several 
genes that were upregulated in Phd2-inactivated AMs 
(including Rgs5, Cox4i2 and Adora2a) are very highly and 
specifically expressed in normal carotid body type I cells 
(Zhou et al. 2016), a cell type that responds to low oxygen 
with the rapid release of neurotransmitters to mediate 
hypoxic ventilatory control in what is termed acute 
oxygen sensing (Gao et al. 2019). Chromaffin cells are also 
reportedly acutely oxygen-sensitive during development, 
but this is lost in adulthood (Thompson et al. 1997). The 
retention of an immature phenotype in AMs with Phd2 
inactivation may extend beyond gene expression to 
include retention of acute oxygen sensitivity. In future 
studies, it will be of interest to determine the extent to 
which Phd2 inactivation in the AM recreates oxygen 
sensitivity in the adult.
https://doi.org/10.1530/ERC-21-0211
https://erc.bioscientifica.com © 2021 The authors
Printed in Great Britain
Published by Bioscientifica Ltd.
This work is licensed under a Creative Commons 
Attribution 4.0 International License.
770L Eckardt, M Prange-
Barczynska et al.
The role of PHD2 in 
pseudohypoxic PCCs
28:12Endocrine-Related 
Cancer
Supplementary materials
This is linked to the online version of the paper at https://doi.org/10.1530/
ERC-21-0211.
Declaration of interest
P J R is a scientific co-founder of, and holds equity in, ReOx Ltd, a University 
spin-out company that seeks to develop therapeutic HIF hydroxylases 
inhibitors and a non-executive director of Immunocore Holdings PLC. 
E J H is employed under the Cambridge Experimental Medicine Initiative, 
partly funded by AstraZeneca, although they have not been involved in this 
project. The other authors declare no financial interests.
Funding
Funding for the work was received from the Oxford Branch of the Ludwig 
Institute for Cancer Research, the Wellcome Trust (106241/Z/14/Z) and 
the Paradifference Foundation. This work was also supported by the 
Francis Crick Institute, which receives its core funding from Cancer 
Research UK (FC001501), the UK Medical Research Council (FC001501), 
and the Wellcome Trust (FC001501). L E was sponsored by an MD 
fellowship from Boehringer Ingelheim Fonds; J D C C L by a FAPESP 
fellowship (2018/20083-1); S K by a Christopher Welch Scholarship and 
the Clarendon Fund.
Author contribution statement
Experiments were designed by L E, M P B, P J R and T B. Data were collected 
and analysed by all authors. Manuscript was prepared by L E, M P B, P J R 
and T B and reviewed by all authors. Figures were prepared and statistical 
analyses performed by L E and M P B with input from other authors. P J R 
and T B conceived the study and managed the project. P J R and T B are 
co-senior authors.
Acknowledgement
The authors thank Douglas Dos Santos Passos and Jade Harris for their 
help in various forms.
References
Al Khazal F, Kang S, Nelson Holte M, Choi DS, Singh R, Ortega-Sáenz P, 
López-Barneo J & Maher 3rd LJ 2021 Unexpected obesity, rather than 
tumorigenesis, in a conditional mouse model of mitochondrial 
complex II deficiency. FASEB Journal 35 e21227. (https://doi.
org/10.1096/fj.202002100R)
Bankhead P, Loughrey MB, Fernández JA, Dombrowski Y, McArt DG, 
Dunne PD, Mcquaid S, Gray RT, Murray LJ, Coleman HG, et al. 2017 
QuPath: open source software for digital pathology image analysis. 
Scientific Reports 7 16878. (https://doi.org/10.1038/s41598-017-17204-5)
Bayley JP, Van Minderhout I, Hogendoorn PC, Cornelisse CJ, Van Der 
Wal A, Prins FA, Teppema L, Dahan A, Devilee P & Taschner PE 2009 
Sdhd and SDHD/H19 knockout mice do not develop paraganglioma or 
pheochromocytoma. PLoS ONE 4 e7987. (https://doi.org/10.1371/
journal.pone.0007987)
Bishop T & Ratcliffe PJ 2014 Signaling hypoxia by hypoxia-inducible factor 
protein hydroxylases: a historical overview and future perspectives. 
Hypoxia 2 197–213. (https://doi.org/10.2147/HP.S47598)
Bishop T, Gallagher D, Pascual A, Lygate CA, De Bono JP, Nicholls LG, 
Ortega-Saenz P, Oster H, Wijeyekoon B, Sutherland AI, et al. 2008 
Abnormal sympathoadrenal development and systemic hypotension 
in PHD3-/- mice. Molecular and Cellular Biology 28 3386–3400. (https://
doi.org/10.1128/MCB.02041-07)
Bishop T, Talbot NP, Turner PJ, Nicholls LG, Pascual A, Hodson EJ, 
Douglas G, Fielding JW, Smith TG, Demetriades M, et al. 2013 Carotid 
body hyperplasia and enhanced ventilatory responses to hypoxia in 
mice with heterozygous deficiency of PHD2. Journal of Physiology 591 
3565–3577. (https://doi.org/10.1113/jphysiol.2012.247254)
Buffet A, Burnichon N, Favier J & Gimenez-Roqueplo AP 2020 An 
overview of 20 years of genetic studies in pheochromocytoma and 
paraganglioma. Best Practice and Research: Clinical Endocrinology and 
Metabolism 34 101416. (https://doi.org/10.1016/j.beem.2020.101416)
Burnichon N, Vescovo L, Amar L, Libe R, De Reynies A, Venisse A, 
Jouanno E, Laurendeau I, Parfait B, Bertherat J, et al. 2011 Integrative 
genomic analysis reveals somatic mutations in pheochromocytoma 
and paraganglioma. Human Molecular Genetics 20 3974–3985. (https://
doi.org/10.1093/hmg/ddr324)
Chan WH, Komada M, Fukushima T, Southard-Smith EM, Anderson CR & 
Wakefield MJ 2019 RNA-seq of isolated chromaffin cells highlights the 
role of sex-linked and imprinted genes in adrenal medulla 
development. Scientific Reports 9 3929. (https://doi.org/10.1038/
s41598-019-40501-0)
Cheng X, Prange-Barczynska M, Fielding JW, Zhang M, Burrell AL, 
Lima JD, Eckardt L, Argles I, Pugh CW, Buckler KJ, et al. 2020 Marked 
and rapid effects of pharmacological HIF-2α antagonism on hypoxic 
ventilatory control. Journal of Clinical Investigation 130 2237–2251. 
(https://doi.org/10.1172/JCI133194)
Choueiri TK & Kaelin Jr WG 2020 Targeting the HIF2-VEGF axis in renal 
cell carcinoma. Nature Medicine 26 1519–1530. (https://doi.
org/10.1038/s41591-020-1093-z)
Coupland RE 1965 The Natural History of Chromaffin Cell. London, UK: 
Longmans.
Coupland RE & Hopwood D 1966 Mechanism of a histochemical reaction 
differentiating between adrenaline- and noradrenaline-storing cells in 
the electron microscope. Nature 209 590–591. (https://doi.
org/10.1038/209590a0)
Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, 
Haase VH & Jaenisch R, Corr M, Nizet V 2003 HIF-1alpha is essential 
for myeloid cell-mediated inflammation. Cell 112 645–657. (https://
doi.org/10.1016/s0092-8674(03)00154-5)
Crona J, Taïeb D & Pacak K 2017 New perspectives on pheochromocytoma 
and paraganglioma: toward a molecular classification. Endocrine 
Reviews 38 489–515. (https://doi.org/10.1210/er.2017-00062)
Dahia PL, Ross KN, Wright ME, Hayashida CY, Santagata S, Barontini M, 
Kung AL, Sanso G, Powers JF, Tischler AS, et al. 2005 A HIF1alpha 
regulatory loop links hypoxia and mitochondrial signals in 
pheochromocytomas. PLoS Genetics 1 72–80. (https://doi.org/10.1371/
journal.pgen.0010008)
Díaz-Castro B, Pintado CO, García-Flores P, López-Barneo J & Piruat JI 
2012 Differential impairment of catecholaminergic cell maturation 
and survival by genetic mitochondrial complex II dysfunction. 
Molecular and Cellular Biology 32 3347–3357. (https://doi.org/10.1128/
MCB.00128-12)
Eisenhofer G, Walther MM, Huynh TT, Li ST, Bornstein SR, Vortmeyer A, 
Mannelli M, Goldstein DS, Linehan WM, Lenders JW, et al. 2001 
Pheochromocytomas in von Hippel-Lindau syndrome and multiple 
endocrine neoplasia type 2 display distinct biochemical and clinical 
phenotypes. Journal of Clinical Endocrinology and Metabolism 86  
1999–2008. (https://doi.org/10.1210/jcem.86.5.7496)
Favier J, Brière JJ, Burnichon N, Rivière J, Vescovo L, Benit P, Giscos-
Douriez I, De Reyniès A, Bertherat J, Badoual C, et al. 2009 The 
Warburg effect is genetically determined in inherited 
pheochromocytomas. PLoS ONE 4 e7094. (https://doi.org/10.1371/
journal.pone.0007094)
https://doi.org/10.1530/ERC-21-0211
https://erc.bioscientifica.com © 2021 The authors
Printed in Great Britain
Published by Bioscientifica Ltd.
This work is licensed under a Creative Commons 
Attribution 4.0 International License.
771L Eckardt, M Prange-
Barczynska et al.
The role of PHD2 in 
pseudohypoxic PCCs
28:12Endocrine-Related 
Cancer
Favier J, Buffet A & Gimenez-Roqueplo AP 2012 HIF2A mutations in 
paraganglioma with polycythemia. New England Journal of Medicine 
367 2161; author reply 2161–2162. (https://doi.org/10.1056/
NEJMc1211953)
Fielding JW, Hodson EJ, Cheng X, Ferguson DJP, Eckardt L, Adam J, Lip P, 
Maton-Howarth M, Ratnayaka I, Pugh CW, et al. 2018 PHD2 
inactivation in Type I cells drives HIF-2alpha-dependent multilineage 
hyperplasia and the formation of paraganglioma-like carotid bodies. 
Journal of Physiology 596 4393–4412. (https://doi.org/10.1113/
JP275996)
Fishbein L & Wilkerson MD 2018 Chromaffin cell biology: inferences from 
the Cancer Genome Atlas. Cell and Tissue Research 372 339–346. 
(https://doi.org/10.1007/s00441-018-2795-0)
Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, 
Lichtenberg TM, Murray BA, Ghayee HK, Else T, et al. 2017 
Comprehensive molecular characterization of pheochromocytoma 
and paraganglioma. Cancer Cell 31 181–193. (https://doi.org/10.1016/j.
ccell.2017.01.001)
Furlan A, Dyachuk V, Kastriti ME, Calvo-Enrique L, Abdo H, Hadjab S, 
Chontorotzea T, Akkuratova N, Usoskin D, Kamenev D, et al. 2017 
Multipotent peripheral glial cells generate neuroendocrine cells of the 
adrenal medulla. Science 357 eaal3753. (https://doi.org/10.1126/
science.aal3753)
Gao L, Ortega-Sáenz P & López-Barneo J 2019 Acute oxygen sensing-Role 
of metabolic specifications in peripheral chemoreceptor cells. 
Respiratory Physiology and Neurobiology 265 100–111. (https://doi.
org/10.1016/j.resp.2018.08.007)
Gruber M, Hu CJ, Johnson RS, Brown EJ, Keith B & Simon MC 2007 Acute 
postnatal ablation of Hif-2alpha results in anemia. PNAS 104  
2301–2306. (https://doi.org/10.1073/pnas.0608382104)
Hanemaaijer ES, Margaritis T, Sanders K, Bos FL, Candelli T, Al-Saati H, 
Van Noesel MM, Meyer-Wentrup FAG, Van De Wetering M, 
Holstege FCP, et al. 2021 Single-cell atlas of developing murine adrenal 
gland reveals relation of Schwann cell precursor signature to 
neuroblastoma phenotype. PNAS 118 e2022350118. (https://doi.
org/10.1073/pnas.2022350118)
Hodson EJ, Nicholls LG, Turner PJ, Llyr R, Fielding JW, Douglas G, 
Ratnayaka I, Robbins PA, Pugh CW, Buckler KJ, et al. 2016 Regulation 
of ventilatory sensitivity and carotid body proliferation in hypoxia by 
the PHD2/HIF-2 pathway. Journal of Physiology 594 1179–1195. 
(https://doi.org/10.1113/JP271050)
Jin Y, An X, Ye Z, Cully B, Wu J & Li J 2009 RGS5, a hypoxia-inducible 
apoptotic stimulator in endothelial cells. Journal of Biological Chemistry 
284 23436–23443. (https://doi.org/10.1074/jbc.M109.032664)
Kaelin Jr WG 2008 The von Hippel-Lindau tumour suppressor protein: O2 
sensing and cancer. Nature Reviews: Cancer 8 865–873. (https://doi.
org/10.1038/nrc2502)
Ladroue C, Carcenac R, Leporrier M, Gad S, Le Hello C, Galateau-Salle F, 
Feunteun J, Pouysségur J, Richard S & Gardie B 2008 PHD2 mutation 
and congenital erythrocytosis with paraganglioma. New England 
Journal of Medicine 359 2685–2692. (https://doi.org/10.1056/
NEJMoa0806277)
Lee S, Nakamura E, Yang H, Wei W, Linggi MS, Sajan MP, Farese RV, 
Freeman RS, Carter BD, Kaelin Jr WG, et al. 2005 Neuronal apoptosis 
linked to EglN3 prolyl hydroxylase and familial pheochromocytoma 
genes: developmental culling and cancer. Cancer Cell 8 155–167. 
(https://doi.org/10.1016/j.ccr.2005.06.015)
Lepoutre-Lussey C, Thibault C, Buffet A, Morin A, Badoual C, Bénit P, 
Rustin P, Ottolenghi C, Janin M, Castro-Vega LJ, et al. 2016 From Nf1 to 
Sdhb knockout: successes and failures in the quest for animal models 
of pheochromocytoma. Molecular and Cellular Endocrinology 421  
40–48. (https://doi.org/10.1016/j.mce.2015.06.027)
Lindeberg J, Usoskin D, Bengtsson H, Gustafsson A, Kylberg A, 
Söderström S & Ebendal T 2004 Transgenic expression of Cre 
recombinase from the tyrosine hydroxylase locus. Genesis 40 67–73. 
(https://doi.org/10.1002/gene.20065)
Lorenzo FR, Yang C, Ng Tang Fui M, Vankayalapati H, Zhuang Z, Huynh T, 
Grossmann M, Pacak K & Prchal JT 2013 A novel EPAS1/HIF2A 
germline mutation in a congenital polycythemia with paraganglioma. 
Journal of Molecular Medicine 91 507–512. (https://doi.org/10.1007/
s00109-012-0967-z)
Macias D, Fernandez-Aguera MC, Bonilla-Henao V & Lopez-Barneo J 2014 
Deletion of the von Hippel-Lindau gene causes sympathoadrenal cell 
death and impairs chemoreceptor-mediated adaptation to hypoxia. 
EMBO Molecular Medicine 6 1577–1592. (https://doi.org/10.15252/
emmm.201404153)
Macias D, Cowburn AS, Torres-Torrelo H, Ortega-Saenz P, Lopez-Barneo J 
& Johnson RS 2018 HIF-2alpha is essential for carotid body 
development and function. eLife 7 e34681. (https://doi.org/10.7554/
eLife.34681)
Mazzone M, Dettori D, De Oliveira RL, Loges S, Schmidt T, Jonckx B, 
Tian YM, Lanahan AA, Pollard P, De Almodovar CR, et al. 2009 
Heterozygous deficiency of PHD2 restores tumor oxygenation and 
inhibits metastasis via endothelial normalization. Cell 136 839–851. 
(https://doi.org/10.1016/j.cell.2009.01.020)
Nagendran M, Riordan DP, Harbury PB & Desai TJ 2018 Automated cell-
type classification in intact tissues by single-cell molecular profiling. 
eLife 7 e30510. (https://doi.org/10.7554/eLife.30510)
Opotowsky AR, Moko LE, Ginns J, Rosenbaum M, Greutmann M, 
Aboulhosn J, Hageman A, Kim Y, Deng LX, Grewal J, et al. 2015 
Pheochromocytoma and paraganglioma in cyanotic congenital heart 
disease. Journal of Clinical Endocrinology and Metabolism 100  
1325–1334. (https://doi.org/10.1210/jc.2014-3863)
Park WJ, Brenner O, Kogot-Levin A, Saada A, Merrill Jr AH, Pewzner-Jung Y 
& Futerman AH 2015 Development of pheochromocytoma in 
ceramide synthase 2 null mice. Endocrine-Related Cancer 22 623–632. 
(https://doi.org/10.1530/ERC-15-0058)
Piruat JI, Pintado CO, Ortega-Sáenz P, Roche M & López-Barneo J 2004 
The mitochondrial SDHD gene is required for early embryogenesis, 
and its partial deficiency results in persistent carotid body glomus cell 
activation with full responsiveness to hypoxia. Molecular and Cellular 
Biology 24 10933–10940. (https://doi.org/10.1128/MCB.24.24.10933-
10940.2004)
Rotolo T, Smallwood PM, Williams J & Nathans J 2008 Genetically-
directed, cell type-specific sparse labeling for the analysis of neuronal 
morphology. PLoS ONE 3 e4099. (https://doi.org/10.1371/journal.
pone.0004099)
Semenza GL 2019 Pharmacologic targeting of hypoxia-inducible factors. 
Annual Review of Pharmacology and Toxicology 59 379–403. (https://doi.
org/10.1146/annurev-pharmtox-010818-021637)
Shen C, Beroukhim R, Schumacher SE, Zhou J, Chang M, Signoretti S & 
Kaelin Jr WG 2011 Genetic and functional studies implicate HIF1α as a 
14q kidney cancer suppressor gene. Cancer Discovery 1 222–235. 
(https://doi.org/10.1158/2159-8290.CD-11-0098)
Smith-Hicks CL, Sizer KC, Powers JF, Tischler AS & Costantini F 2000 
C-cell hyperplasia, pheochromocytoma and sympathoadrenal 
malformation in a mouse model of multiple endocrine neoplasia type 
2B. EMBO Journal 19 612–622. (https://doi.org/10.1093/
emboj/19.4.612)
Tai TC, Wong-Faull DC, Claycomb R & Wong DL 2009 Hypoxic stress-
induced changes in adrenergic function: role of HIF1 alpha. Journal of 
Neurochemistry 109 513–524. (https://doi.
org/10.1111/j.1471-4159.2009.05978.x)
Thompson RJ, Jackson A & Nurse CA 1997 Developmental loss of hypoxic 
chemosensitivity in rat adrenomedullary chromaffin cells. Journal of 
Physiology 498 503–510. (https://doi.org/10.1113/jphysiol.1997.sp021876)
Tischler AS 2008 Pheochromocytoma and extra-adrenal paraganglioma: 
updates. Archives of Pathology and Laboratory Medicine 132 1272–1284. 
(https://doi.org/10.5858/2008-132-1272-PAEPU)
Toledo RA 2017 New HIF2α inhibitors: potential implications as therapeutics 
for advanced pheochromocytomas and paragangliomas. Endocrine-
Related Cancer 24 C9–C19. (https://doi.org/10.1530/ERC-16-0479)
https://doi.org/10.1530/ERC-21-0211
https://erc.bioscientifica.com © 2021 The authors
Printed in Great Britain
Published by Bioscientifica Ltd.
This work is licensed under a Creative Commons 
Attribution 4.0 International License.
772L Eckardt, M Prange-
Barczynska et al.
The role of PHD2 in 
pseudohypoxic PCCs
28:12Endocrine-Related 
Cancer
Toledo RA, Qin Y, Srikantan S, Morales NP, Li Q, Deng Y, Kim SW, 
Pereira MA, Toledo SP, Su X, et al. 2013 In vivo and in vitro oncogenic 
effects of HIF2A mutations in pheochromocytomas and 
paragangliomas. Endocrine-Related Cancer 20 349–359. (https://doi.
org/10.1530/ERC-13-0101)
Vaidya A, Flores SK, Cheng ZM, Nicolas M, Deng Y, Opotowsky AR, 
Lourenço Jr DM, Barletta JA, Rana HQ, Pereira MA, et al. 2018 EPAS1 
mutations and paragangliomas in cyanotic congenital heart disease. 
New England Journal of Medicine 378 1259–1261. (https://doi.
org/10.1056/NEJMc1716652)
Verhofstad AA, Hökfelt T, Goldstein M, Steinbusch HW & Joosten HW 
1979 Appearance of tyrosine hydroxylase, aromatic amino-acid 
decarboxylase, dopamine beta-hydroxylase and 
phenylethanolamine N-methyltransferase during the ontogenesis 
of the adrenal medulla: an immunohistochemical study in the rat. 
Cell and Tissue Research 200 1–13. (https://doi.org/10.1007/
BF00236882)
Vollmer RR 1996 Selective neural regulation of epinephrine and 
norepinephrine cells in the adrenal medulla – cardiovascular 
implications. Clinical and Experimental Hypertension 18 731–751. 
(https://doi.org/10.3109/10641969609081778)
Vooijs M, Jonkers J & Berns A 2001 A highly efficient ligand-regulated Cre 
recombinase mouse line shows that LoxP recombination is position 
dependent. EMBO Reports 2 292–297. (https://doi.org/10.1093/embo-
reports/kve064)
Waldmann J, Fendrich V, Holler J, Buchholz M, Heinmöller E, Langer P, 
Ramaswamy A, Samans B, Walz MK, Rothmund M, et al. 2010 
Microarray analysis reveals differential expression of benign and 
malignant pheochromocytoma. Endocrine-Related Cancer 17 743–756. 
(https://doi.org/10.1677/ERC-09-0118)
Welander J, Andreasson A, Brauckhoff M, Bäckdahl M, Larsson C, 
Gimm O & Söderkvist P 2014 Frequent EPAS1/HIF2α exons 9 and 12 
mutations in non-familial pheochromocytoma. Endocrine-Related 
Cancer 21 495–504. (https://doi.org/10.1530/ERC-13-0384)
Yang C, Zhuang Z, Fliedner SM, Shankavaram U, Sun MG, Bullova P, Zhu R, 
Elkahloun AG, Kourlas PJ, Merino M, et al. 2015 Germ-line PHD1 and 
PHD2 mutations detected in patients with pheochromocytoma/
paraganglioma-polycythemia. Journal of Molecular Medicine 93 93–104. 
(https://doi.org/10.1007/s00109-014-1205-7)
Zhou T, Chien MS, Kaleem S & Matsunami H 2016 Single cell 
transcriptome analysis of mouse carotid body glomus cells. Journal of 
Physiology 594 4225–4251. (https://doi.org/10.1113/JP271936)
Zhuang Z, Yang C, Lorenzo F, Merino M, Fojo T, Kebebew E, Popovic V, 
Stratakis CA, Prchal JT & Pacak K 2012 Somatic HIF2A gain-of-function 
mutations in paraganglioma with polycythemia. New England Journal 
of Medicine 367 922–930. (https://doi.org/10.1056/NEJMoa1205119)
Received in final form 1 September 2021
Accepted 20 September 2021
Accepted Manuscript published online 20 September 2021
https://doi.org/10.1530/ERC-21-0211
https://erc.bioscientifica.com © 2021 The authors
Printed in Great Britain
Published by Bioscientifica Ltd.
This work is licensed under a Creative Commons 
Attribution 4.0 International License.
